IOVS BJO
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berson, E. L.
Right arrow Articles by Dryja, T. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berson, E. L.
Right arrow Articles by Dryja, T. P.
(Investigative Ophthalmology and Visual Science. 2001;42:2217-2224.)
© 2001 by The Association for Research in Vision and Ophthalmology, Inc.

Clinical Features and Mutations in Patients with Dominant Retinitis Pigmentosa-1 (RP1)

Eliot L. Berson1, Jonna L. Grimsby1, Scott M. Adams1, Terri L. McGee1, Elizabeth Sweklo1, Eric A. Pierce2, Michael A. Sandberg1 and Thaddeus P. Dryja1

1 From the Berman-Gund Laboratory for the Study of Retinal Degenerations and the Ocular Molecular Genetics Institute, Harvard Medical School and the Massachusetts Eye and Ear Infirmary, Boston, Massachusetts; and the 2 F. M. Kirby Center for Molecular Ophthalmology, University of Pennsylvania, Scheie Eye Institute, Philadelphia, Pennsylvania.

PURPOSE. To survey patients with dominant retinitis pigmentosa (RP) for mutations in the RP1 gene to determine the spectrum of dominant mutations in this gene, to estimate the proportion of dominant RP caused by this gene, and to determine whether the clinical features of patients with RP1 mutations differ from features of those with rhodopsin mutations.

METHODS. A set of 241 patients who did not have mutations in the rhodopsin gene (based on previous work) formed the basis for the study. Of these patients, 117 had also been previously evaluated and were found not to carry mutations in the RDS gene. The single-strand conformation polymorphism (SSCP) method was used to search for sequence variants, which were then directly sequenced. The relatives of selected patients were recruited for segregation analyses. Clinical evaluations of patients included a measurement of Snellen visual acuity, final dark adaptation thresholds, visual fields, and ERGs. Clinical data were compared with those obtained earlier from a study of 128 patients with dominant rhodopsin mutations.

RESULTS. Of the 241 patients, all were screened for the most common RP1 mutation (Arg677Ter), and 10 patients were found to have this mutation. In addition, an evaluation of a subset of 189 patients in whom the entire coding sequence was evaluated revealed the following mutations: Gln679Ter (1 case), Gly723Ter (2 cases), Glu729(1-bp del) (1 case), Leu762(5-bp del) (2 cases), and Asn763(4-bp del) (1 case). All of these mutations cosegregated with RP in the families of the index patients. Nine missense mutations that were each found in six or fewer patients were encountered. The segregation of eight of these was evaluated in the respective patients’ families, and only one segregated with dominant RP. This cosegregating missense change was in cis with the nonsense mutation Gln679Ter. Although patients with RP1 mutations had, on average, slightly better visual acuity than patients with rhodopsin mutations, there was no statistically significant difference in final dark-adaptation thresholds, visual field diameters, or cone electroretinogram (ERG) amplitudes. Comparably aged patients with RP1 mutations had visual function that varied by approximately two orders of magnitude, based on visual fields and ERG amplitudes.

CONCLUSIONS. Dominant RP1 alleles typically have premature nonsense codons occurring in the last exon of the gene and would be expected to encode mutant proteins that are only approximately one third the size of the wild-type protein, suggesting that a dominant negative effect rather than haploinsufficiency is the mechanism leading to RP caused by RP1 mutations. On average, patients with RP1 mutations have slightly better visual acuity than patients with dominant rhodopsin mutations; otherwise, they have similarly severe disease. The wide range in severity among patients with RP1 mutations indicates that other genetic or environmental factors modulate the effect of the primary mutation.




This article has been cited by other articles:


Home page
IOVSHome page
L. S. Sullivan, S. J. Bowne, D. G. Birch, D. Hughbanks-Wheaton, J. R. Heckenlively, R. A. Lewis, C. A. Garcia, R. S. Ruiz, S. H. Blanton, H. Northrup, et al.
Prevalence of disease-causing mutations in families with autosomal dominant retinitis pigmentosa: a screen of known genes in 200 families.
Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 3052 - 3064.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. A. Riazuddin, F. Zulfiqar, Q. Zhang, Y. V. Sergeev, Z. A. Qazi, T. Husnain, R. Caruso, S. Riazuddin, P. A. Sieving, and J. F. Hejtmancik
Autosomal Recessive Retinitis Pigmentosa Is Associated with Mutations in RP1 in Three Consanguineous Pakistani Families
Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2264 - 2270.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y. Wada, M. A. Sandberg, T. L. McGee, M. A. Stillberger, E. L. Berson, and T. P. Dryja
Screen of the IMPDH1 Gene among Patients with Dominant Retinitis Pigmentosa and Clinical Features Associated with the Most Common Mutation, Asp226Asn
Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1735 - 1741.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
S Khaliq, A Abid, M Ismail, A Hameed, A Mohyuddin, P Lall, A Aziz, K Anwar, and S Q Mehdi
Novel association of RP1 gene mutations with autosomal recessive retinitis pigmentosa
J. Med. Genet., May 1, 2005; 42(5): 436 - 438.
[Full Text] [PDF]


Home page
J. Neurosci.Home page
Q. Liu, J. Zuo, and E. A. Pierce
The Retinitis Pigmentosa 1 Protein Is a Photoreceptor Microtubule-Associated Protein
J. Neurosci., July 21, 2004; 24(29): 6427 - 6436.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Q. Liu, A. Lyubarsky, J. H. Skalet, E. N. Pugh Jr, and E. A. Pierce
RP1 Is Required for the Correct Stacking of Outer Segment Discs
Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4171 - 4183.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. B. Schwartz, T. S. Aleman, A. V. Cideciyan, A. Swaroop, S. G. Jacobson, and E. M. Stone
De Novo Mutation in the RP1 Gene (Arg677ter) Associated with Retinitis Pigmentosa
Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3593 - 3597.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Gao, K. Cheon, S. Nusinowitz, Q. Liu, D. Bei, K. Atkins, A. Azimi, S. P. Daiger, D. B. Farber, J. R. Heckenlively, et al.
Progressive photoreceptor degeneration, outer segment dysplasia, and rhodopsin mislocalization in mice with targeted disruption of the retinitis pigmentosa-1 (Rp1) gene
PNAS, April 16, 2002; 99(8): 5698 - 5703.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Association for Research in Vision and Ophthalmology